Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting Viral Pathogens
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 1, 2023
March 2, 2023
1953041c-b51e-461d-b446-46cb6faf0d86
Related Documents
Clinical Pharmacology Considerations for Peptide Drug Products
Guidance DocumentDecember 14, 2023Center for Drug Evaluation and Research
Psychedelic Drugs: Considerations for Clinical Investigations
Guidance DocumentJune 23, 2023Center for Drug Evaluation and Research
Benefit-Risk Considerations for Product Quality Assessments
Guidance DocumentMay 9, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox